Familial hypocalciuric hypercalcemia

Familial hypocalciuric hypercalcemia is usually caused by a change in the calcium-sensing receptor gene (CASR).
Some risks are written in our DNA, passed down through families.
It follows an autosomal dominant pattern, so a child has a 50% chance to inherit it if one parent is affected.
Less often, changes in GNA11 or AP2S1 cause similar forms, and a new mutation can appear with no family history.
Risk factors for familial hypocalciuric hypercalcemia are mainly genetic, but dehydration or medicines like thiazide water pills or lithium can raise calcium levels and make it more noticeable.

Genetic risk factors

Familial hypocalciuric hypercalcemia (FHH) is almost always driven by changes in genes that control how the body senses calcium levels. Some risk factors are inherited through our genes. The genetic causes of familial hypocalciuric hypercalcemia usually run in families in an autosomal dominant pattern, meaning a parent with the change has a 50% chance to pass it on. Rarely, a new change arises for the first time in a child without a prior family history.

• Autosomal dominance: A parent with FHH has a 50% chance of passing the gene change to each child. This inheritance pattern affects all sexes equally. Severity can vary among relatives who share the same change.

• CASR variants: Most cases come from changes in the CASR gene, which lowers the cell’s sensitivity to calcium. This raises the body’s set-point for calcium, leading to lifelong mild high blood calcium. Family members with the same change often have similar lab patterns.

• AP2S1 variants: Changes in the AP2S1 gene can cause a form known as FHH type 3. These variants alter how the calcium-sensing receptor is trafficked inside cells, reducing the signal. Some people with this form can have slightly higher calcium levels or more noticeable lab differences.

• GNA11 variants: Rare changes in the GNA11 gene disrupt signaling downstream of the calcium-sensing receptor. This can produce familial hypocalciuric hypercalcemia that looks very similar to CASR-related FHH. Families with this variant often have a consistent pattern across generations.

• De novo variants: Sometimes a gene change causing FHH appears for the first time in a child, with no prior family history. That individual can still pass it to future children in the same autosomal dominant way. Genetic counseling can help clarify family risk.

• Variable expression: People with the same variant can have different calcium levels and different ages at detection. Many feel well and learn about FHH after routine tests. This variability can make early recognition within families challenging.

• Family history: Multiple relatives with long-standing mild high calcium suggest an inherited cause like familial hypocalciuric hypercalcemia. Patterns across several generations raise the likelihood of a gene change. Sharing this information with clinicians can guide genetic testing.

Transmission

Familial hypocalciuric hypercalcemia is not contagious; you can’t catch it or pass it by contact. In most families, the genetic transmission of Familial hypocalciuric hypercalcemia follows a dominant pattern—if one parent has it, each child has a 50% chance of inheriting the condition. Some people are the first in their family because of a new (de novo) change in a gene that helps the body sense calcium, and they can pass it on to their children in the same way. If you’re wondering how Familial hypocalciuric hypercalcemia is inherited in your family, a genetics clinic can review your history and discuss testing for you and close relatives.

When to test your genes

Consider genetic testing if you have lifelong mild high calcium with low urine calcium, especially if multiple relatives share it or if a doctor suspects FHH versus primary hyperparathyroidism. Test before parathyroid surgery to avoid an unnecessary operation. It also helps tailor monitoring in pregnancy, childhood, and when interpreting calcium or vitamin D treatment.

Daily routines often adapt as people with familial hypocalciuric hypercalcemia learn what their usual calcium levels look like and which symptoms matter. Many people find that symptoms are mild or absent, and the condition stays stable for life. Doctors call this the prognosis—a medical word for likely outcomes. Most people with familial hypocalciuric hypercalcemia have a normal life expectancy, and the condition rarely leads to organ damage, kidney stones, or fractures. Early care can make a real difference by preventing unnecessary treatments, like parathyroid surgery, which typically does not help in this condition.

The outlook is not the same for everyone, but most have a lifelong, gentle elevation of calcium with low urine calcium and no major complications. Some people experience fatigue, muscle aches, or foggy thinking, while others notice no day‑to‑day effects at all. A small subset with certain gene changes can have higher calcium levels and, rarely, pancreatitis or issues with the kidneys; these cases need closer follow‑up. When thinking about the future, it helps to know that early symptoms of familial hypocalciuric hypercalcemia can overlap with primary hyperparathyroidism—getting the diagnosis right guides the safest plan.

With ongoing care, many people maintain good quality of life without medication. Genetic testing can sometimes provide more insight into prognosis, especially for families planning pregnancies or when calcium levels are higher than expected. Support from friends and family can make it easier to track symptoms and attend routine checks. Talk with your doctor about what your personal outlook might look like, including how often to monitor calcium and whether relatives should be tested.

Familial hypocalciuric hypercalcemia is usually mild and doesn’t need treatment because calcium levels are only slightly high and the body adapts. Most people are managed with watchful waiting: regular blood tests, staying well hydrated, and avoiding unnecessary calcium-raising medicines like high-dose calcium or vitamin D unless your doctor advises otherwise. If symptoms such as fatigue, muscle aches, or constipation trouble you, supportive care can make a real difference in how you feel day to day. Doctors may consider a calcimimetic drug (such as cinacalcet) in select cases with bothersome symptoms or very high calcium, but surgery on the parathyroid glands is not recommended because it doesn’t fix this genetic condition. It’s natural to have questions about the best plan for you, so ask your doctor about the best starting point for you.

In most families, this condition is inherited in a dominant pattern—if a parent has it, each child has about a 1 in 2 (50%) chance of inheriting it. It most often stems from a change in the calcium-sensing receptor gene (called CASR), which shifts the body’s “set point” for calcium so blood levels run a bit high while urine calcium stays low. Less commonly, changes in other related genes can lead to the same pattern. DNA testing can sometimes identify these changes. Because early symptoms of Familial hypocalciuric hypercalcemia are often subtle or even absent, family history and a consistent lab pattern are key clues. Occasionally, the gene change arises for the first time in a family, and very rarely, changes in both copies of the gene cause a different, more severe condition in newborns. Confirming the genetic cause helps tell it apart from other reasons for high calcium, such as overactive parathyroid glands, and can prevent tests or surgeries that aren’t needed.

When familial hypocalciuric hypercalcemia occurs alongside other conditions that affect calcium balance, lab results and symptoms can be harder to interpret. If new or early symptoms of familial hypocalciuric hypercalcemia suddenly worsen, clinicians also look for another cause of high calcium, such as primary hyperparathyroidism, certain cancers, or illnesses like sarcoidosis; this matters because parathyroid surgery helps in primary hyperparathyroidism but not in familial hypocalciuric hypercalcemia alone. Low vitamin D levels or chronic kidney disease can lower calcium in the urine and blur the usual testing pattern, so correcting these issues first often clarifies the picture. Some medicines—especially thiazide water pills and lithium—can raise blood calcium and reduce urine calcium, which may amplify the appearance of the condition or mask another problem. People with both familial hypocalciuric hypercalcemia and primary hyperparathyroidism may face higher calcium levels and a greater chance of kidney stones or bone loss than with either condition alone. Talk with your doctor about how your conditions may influence each other, including whether any medications should be adjusted and which tests can best separate one cause from another.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.